Released on Friday, February 7, the January jobs report showed resilience in the labor market with higher-than-expected wage ...

Lilly will provide an initial payment to complete a Phase I trial of OLX75016, which started in February 2024.

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...

Debate over childhood obesity treatments: weight-loss drugs vs. lifestyle changes, with concerns about long-term effects.

Innogen, a Shanghai-based medical technology company, announced that its independently developed, human-derived, ...